MET and glioma: Mechanistically, LINC00998 prevented CBX3 ubiquitination and promoted tri-methylation of histone H3K9 in c-Met promoter region, further downregulated the c-Met/Akt/mTOR signaling pathway, and then attenuated glioma progression.